Form 4 for VERA Vera Therapeutics, Inc.
Accepted 2023-06-23 00:00:00 ET · period of report 2023-06-23 · accession 0001209191-23-039323 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-06-23 | 2023-06-23 | VERA | Grant Sean | CFO | P - Purchase | $16.60 | +5,000 | 5,992 | +504% | +$83.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-06-23 | P | A | 5,000 | $16.60 | 5,992 | I By Trust | — | — |